PICO Portalanswers from OpenAlex

Serum asymmetric dimethylarginine (ADMA) level and cognitive dysfunction in diabetic patients

PaperCitations, authors & open-access status

Serum asymmetric dimethylarginine (ADMA) level and cognitive dysfunction in diabetic patients is a paper indexed in PICO Portal from OpenAlex.

How many citations does Serum asymmetric dimethylarginine (ADMA) level and cognitive dysfunction in diabetic patients have?

PICO Portalcitation count

Serum asymmetric dimethylarginine (ADMA) level and cognitive dysfunction in diabetic patients has 1 citations in the OpenAlex counts PICO Portal stores.

When was Serum asymmetric dimethylarginine (ADMA) level and cognitive dysfunction in diabetic patients published?

PICO Portalyear

Serum asymmetric dimethylarginine (ADMA) level and cognitive dysfunction in diabetic patients has 2022 year in the PICO Portal index.

Open the OpenAlex record →

What is the open-access status of Serum asymmetric dimethylarginine (ADMA) level and cognitive dysfunction in diabetic patients?

PICO Portaloa status

Serum asymmetric dimethylarginine (ADMA) level and cognitive dysfunction in diabetic patients has closed oa status in the PICO Portal index.

Open the OpenAlex record →

What is the DOI of Serum asymmetric dimethylarginine (ADMA) level and cognitive dysfunction in diabetic patients?

PICO Portaldoi

The DOI for Serum asymmetric dimethylarginine (ADMA) level and cognitive dysfunction in diabetic patients is on the source record.

Open the DOI →

What is the OpenAlex record for Serum asymmetric dimethylarginine (ADMA) level and cognitive dysfunction in diabetic patients?

PICO Portalopenalex

The OpenAlex for Serum asymmetric dimethylarginine (ADMA) level and cognitive dysfunction in diabetic patients is on the source record.

Open the OpenAlex →